GPhA And Actavis Divorcing: Biosimilars Behind The Rift

Actavis, the hybridizing generics giant that once helped keep GPhA together, now appears to be splitting off in a dispute over state substitution strategy.

ORLANDO – The Generic Pharmaceutical Association’s annual meeting from Feb. 18-21 was the group’s biggest ever, with 725 attendees. But it would have been more joyous if the association had not been in the midst of a breakup with one of its most prominent members, Allergan PLC.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America